Antibody-Recruiting Molecules: An Emerging Paradigm for Engaging Immune Function in Treating Human Disease
- 3 July 2012
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 7 (7), 1139-1151
- https://doi.org/10.1021/cb300119g
Abstract
Synthetic immunology, the development of synthetic systems capable of modulating and/or manipulating immunological functions, represents an emerging field of research with manifold possibilities. One focus of this area has been to create low molecular weight synthetic species, called antibody-recruiting molecules (ARMs), which are capable of enhancing antibody binding to disease-relevant cells or viruses, thus leading to their immune-mediated clearance. This article provides a thorough discussion of contributions in this area, beginning with the history of small-molecule-based technologies for modulating antibody recognition, followed by a systematic review of the various applications of ARM-based strategies. Thus, we describe ARMs capable of targeting cancer, bacteria, and viral pathogens, along with some of the scientific discoveries that have resulted from their development. Research in this area underscores the many exciting possibilities at the interface of organic chemistry and immunobiology and is positioned to advance both basic and clinical science in the years to come.Keywords
This publication has 168 references indexed in Scilit:
- Identification of Candidate IgG Biomarkers for Alzheimer's Disease via Combinatorial Library ScreeningCell, 2011
- Development of antibody surrogates for the treatment of cancers and autoimmune diseaseCurrent Opinion in Chemical Biology, 2010
- Expanding the Concept of Chemically Programmable Antibodies to RNA Aptamers: Chemically Programmed BiotherapeuticsAngewandte Chemie, 2010
- Monoclonal antibody-based therapies for microbial diseasesVaccine, 2009
- Bioorthogonal Chemistry: Fishing for Selectivity in a Sea of FunctionalityAngewandte Chemie, 2009
- An efficient chemical approach to bispecific antibodies and antibodies of high valencyBioorganic & Medicinal Chemistry Letters, 2009
- β-Lactam-based approach for the chemical programming of aldolase antibody 38C2Bioorganic & Medicinal Chemistry Letters, 2009
- Self‐Assembly of Antibodies by Chemical InductionAngewandte Chemie, 2008
- Display technologies: Application for the discovery of drug and gene delivery agentsAdvanced Drug Delivery Reviews, 2006
- Structural basis for inhibition of the epidermal growth factor receptor by cetuximabCancer Cell, 2005